For patients with type 2 diabetes (T2D), disparities in continuous glucose monitor (CGM) prescriptions are seen by language ...

Explore the robust growth trajectory of the European diabetes market, set to reach $23.78 billion by 2025, with a projected CAGR of 8.0% from 2025-20 ...

The American Diabetes Association, now endorses automated insulin delivery (AID) systems as the leading approach for ...

ALR Technologies SG Ltd. ('ALRT' or the 'Company') (OTCPK: ALRTF), the diabetes management company, announces it has entered into a Definitive Manufacturing Agreement with CGM Medical Technology Shen ...

CGM use vs self-monitoring was not associated with improved obstetric or neonatal outcomes among women with gestational diabetes.